Sanofi India Ratios

Sanofi India Ltd Ratios

The Sanofi India Ltd Ratios page provides a complete fundamental analysis of Sanofi India Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Sanofi India Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Sanofi India Ltd (NSE: SANOFI, BSE: 500674) is currently trading at ₹3965.10, with a market capitalization of ₹91.27B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Sanofi India Ltd remains a key stock for fundamental analysis using Sanofi India Ltd Ratios.

Sanofi India Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Sanofi India Ltd P/E ratio currently stands at 34.11, making it one of the most tracked metrics in Sanofi India Ltd Ratios.

Historically, the Sanofi India Ltd P/E ratio has shown strong fluctuations:

• 2024: 34.11
• 2023: 30.82
• 2022: 21.71
• 2021: 19.25
• 2020: 40.11

The rising Sanofi India Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Sanofi India Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 16.38.

Historical P/B trend:

• 2024: 16.38
• 2023: 18.30
• 2022: 10.56
• 2021: 8.17

Sanofi India Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Sanofi India Ltd P/S ratio currently stands at 7.02, an important part of Sanofi India Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 7.02
• 2023: 9.32
• 2022: 4.87
• 2021: 6.17

A stable or declining Sanofi India Ltd P/S ratio indicates cautious market sentiment.

Sanofi India Ltd Price to Cash Flow Ratio (P/CF)

The Sanofi India Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 29.49.

Historical Sanofi India Ltd Price to Cash Flow Ratio:

• 2024: 29.49
• 2023: 66.86
• 2022: 29.55
• 2021: 29.31
• 2020: 27.86

The declining Sanofi India Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Sanofi India Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Sanofi India Ltd EV currently stands at ₹138.21B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 138.21B
• 2023: 181.92B
• 2022: 124.79B
• 2021: 166.52B

Sanofi India Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Sanofi India Ltd EV/EBITDA ratio is currently 27.58, a key metric in Sanofi India Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 27.58
• 2023: 36.25
• 2022: 17.38
• 2021: 21.74

Stable Sanofi India Ltd EV/EBITDA indicates balanced valuation.

Sanofi India Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Sanofi India Ltd D/E ratio is currently 0.02, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.02
• 2023: 0.02
• 2022: 0.02
• 2021: 0.01

Sanofi India Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Sanofi India Ltd ROE currently stands at 33.45%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 33.45
• 2023: 31.83
• 2022: 35.45
• 2021: 43.47

Sanofi India Ltd demonstrates strong profitability and efficient capital utilization.

Sanofi India Ltd Ratios Analysis Summary

The Sanofi India Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Sanofi India Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Sanofi India Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.